Cell entry mechanisms of SARS-CoV-2

Shang, Jian, Wan, Yushun, Luo, Chuming, Ye, Gang, Geng, Qibin, Auerbach, Ashley, Li, Fang·2020·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.2003138117

Cited by (1,003)

Items 1,001–1,003 of 1,003

  1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
    Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, Ashraf N. Abdalla, Bahaa G. M. Youssif, Nashwa A. Ibrahim, Mohammed Gamal, Hany A.M. El-Sherief, Maha M. Abdel‐Fattah, Ahmed A. Hefny et al. · 2024 · European Journal of Medicinal Chemistry
  2. Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET
    Caner Akıl, Jialu Xu, Juan Shen, Peijun Zhang · 2025 · Nature Communications
  3. Beyond dexamethasone, emerging immuno‐thrombotic therapies for COVID‐19
    Jensen, Melanie Peta, George, Marc, Gilroy, Derek, Sofat, Reecha · 2021 · British Journal of Clinical Pharmacology